Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
589.5 USD | -0.22% | -1.41% | +10.91% |
Financials (USD)
Sales 2024 * | 43.01B | Sales 2025 * | 46.08B | Capitalization | 226B |
---|---|---|---|---|---|
Net income 2024 * | 6.15B | Net income 2025 * | 6.97B | EV / Sales 2024 * | 5.8 x |
Net Debt 2024 * | 23.99B | Net Debt 2025 * | 19.18B | EV / Sales 2025 * | 5.31 x |
P/E ratio 2024 * |
37.2
x | P/E ratio 2025 * |
31.9
x | Employees | 122,000 |
Yield 2024 * |
0.25% | Yield 2025 * |
0.28% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific
1 day | -0.27% | ||
1 week | -1.17% | ||
Current month | +3.77% | ||
1 month | +2.71% | ||
3 months | +4.50% | ||
6 months | +20.25% | ||
Current year | +11.18% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
Director of Finance/CFO | 57 | 01-05-31 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
C. Harris
BRD | Director/Board Member | 67 | 12-03-29 |
Ruby Chandy
BRD | Director/Board Member | 62 | 22-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
11.69% | 2 M€ | -25.75% | ||
7.43% | 17 M€ | +8.31% | - | |
5.37% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 588.7 | -0.36% | 281 452 |
24-05-22 | 590.8 | +0.12% | 872,991 |
24-05-21 | 590.1 | -0.65% | 1,133,164 |
24-05-20 | 594 | -0.22% | 805,710 |
24-05-17 | 595.3 | -0.31% | 1,398,449 |
Delayed Quote Nyse, May 23, 2024 at 10:18 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.18% | 226B | |
+14.90% | 198B | |
+19.46% | 142B | |
+30.19% | 111B | |
+2.55% | 65.26B | |
+17.00% | 54.36B | |
+4.96% | 50.94B | |
+9.14% | 44.8B | |
+3.52% | 36.8B | |
+25.48% | 32.07B |
- Stock Market
- Equities
- TMO Stock